Y-mAbs

-$0.17 (-1.59%) As of 2:46 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO
Claus Juan Møller-San Pedro
Employees
125
Headquarters
New York, New York
Founded
2015

YMAB Key Statistics

Market cap
458.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
419.80K
High today
$11.19
Low today
$10.47
Open price
$11.07
Volume
18.80K
52 Week high
$50.70
52 Week low
$9.67

YMAB Earnings

-$1.01
-$0.42
$0.16
$0.75
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure